Cargando…
Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration
The inertness of synthetic polymer materials and the insufficient mechanical strength of reprocessed decellularized extracellular matrix (dECM) limited their promotive efforts on tissue regeneration. Here, we prepared a hybrid scaffold composed of PCL microfibers and human placental extracellular ma...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486249/ https://www.ncbi.nlm.nih.gov/pubmed/36185748 http://dx.doi.org/10.1016/j.bioactmat.2022.08.018 |
_version_ | 1784792237340622848 |
---|---|
author | Liu, Siyang Yao, Liying Wang, Yumeng Li, Yi Jia, Yanju Yang, Yueyue Li, Na Hu, Yuanjing Kong, Deling Dong, Xianhao Wang, Kai Zhu, Meifeng |
author_facet | Liu, Siyang Yao, Liying Wang, Yumeng Li, Yi Jia, Yanju Yang, Yueyue Li, Na Hu, Yuanjing Kong, Deling Dong, Xianhao Wang, Kai Zhu, Meifeng |
author_sort | Liu, Siyang |
collection | PubMed |
description | The inertness of synthetic polymer materials and the insufficient mechanical strength of reprocessed decellularized extracellular matrix (dECM) limited their promotive efforts on tissue regeneration. Here, we prepared a hybrid scaffold composed of PCL microfibers and human placental extracellular matrix (pECM) nanofibers by co-electrospinning, which was grafted with heparin and further absorbed with IL-4. The hybrid scaffold with improved hemocompatibility firstly switched macrophages to anti-inflammatory phenotype (increased by 18.1%) and then promoted migration, NO production, tube formation of endothelial cells (ECs), and migration and maturation of vascular smooth muscle cells (VSMCs), and ECM deposition in vitro and in vivo. ECs coverage rate increased by 8.6% and the thickness of the smooth muscle layer was 1.8 times more than PCL grafts at 12 wks. Our study realized the complementary advantages of synthetic polymer materials and dECM materials, and opened intriguing perspectives for the design and construction of small-diameter vascular grafts (SDVGs) and immune-regulated materials for other tissue regeneration. |
format | Online Article Text |
id | pubmed-9486249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | KeAi Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-94862492022-09-30 Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration Liu, Siyang Yao, Liying Wang, Yumeng Li, Yi Jia, Yanju Yang, Yueyue Li, Na Hu, Yuanjing Kong, Deling Dong, Xianhao Wang, Kai Zhu, Meifeng Bioact Mater Article The inertness of synthetic polymer materials and the insufficient mechanical strength of reprocessed decellularized extracellular matrix (dECM) limited their promotive efforts on tissue regeneration. Here, we prepared a hybrid scaffold composed of PCL microfibers and human placental extracellular matrix (pECM) nanofibers by co-electrospinning, which was grafted with heparin and further absorbed with IL-4. The hybrid scaffold with improved hemocompatibility firstly switched macrophages to anti-inflammatory phenotype (increased by 18.1%) and then promoted migration, NO production, tube formation of endothelial cells (ECs), and migration and maturation of vascular smooth muscle cells (VSMCs), and ECM deposition in vitro and in vivo. ECs coverage rate increased by 8.6% and the thickness of the smooth muscle layer was 1.8 times more than PCL grafts at 12 wks. Our study realized the complementary advantages of synthetic polymer materials and dECM materials, and opened intriguing perspectives for the design and construction of small-diameter vascular grafts (SDVGs) and immune-regulated materials for other tissue regeneration. KeAi Publishing 2022-09-18 /pmc/articles/PMC9486249/ /pubmed/36185748 http://dx.doi.org/10.1016/j.bioactmat.2022.08.018 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Liu, Siyang Yao, Liying Wang, Yumeng Li, Yi Jia, Yanju Yang, Yueyue Li, Na Hu, Yuanjing Kong, Deling Dong, Xianhao Wang, Kai Zhu, Meifeng Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration |
title | Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration |
title_full | Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration |
title_fullStr | Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration |
title_full_unstemmed | Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration |
title_short | Immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration |
title_sort | immunomodulatory hybrid micro-nanofiber scaffolds enhance vascular regeneration |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486249/ https://www.ncbi.nlm.nih.gov/pubmed/36185748 http://dx.doi.org/10.1016/j.bioactmat.2022.08.018 |
work_keys_str_mv | AT liusiyang immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration AT yaoliying immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration AT wangyumeng immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration AT liyi immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration AT jiayanju immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration AT yangyueyue immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration AT lina immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration AT huyuanjing immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration AT kongdeling immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration AT dongxianhao immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration AT wangkai immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration AT zhumeifeng immunomodulatoryhybridmicronanofiberscaffoldsenhancevascularregeneration |